• All threads and posts regarding Coronavirus COVID-19 can now be found in our new area specifically for Coronavirus COVID-19 discussion.

    You can directly access this area >here<.

NICE draft guidance


Registered User
Feb 15, 2005

I am the new press officer at the Society. I am currently preparing for the NICE draft guidance on anti dementia drugs which is due to be published shortly.

I am looking for carers and people with Alzheimer's who would be willing to talk to the media about their experiences of drug treatments, particularly Exelon and Reminyl.

Please reply to this link, email me at gwing@alzheimers.org.uk or call me on 020 7306 0839 to discuss your experiences.

Many thanks,